title: Synthesis and electrochemical study of a new chiral tris-catecholamide analogue of enterobactin.
abstract: The comparison of siderophore complex redox potentials with those of physiological reductants may aid in the clarification of the mechanism of iron metabolism. In this paper, a new chiral tris-catecholamide compound N,N',N''-tris-(2,3-dihydroxybenzoyl)-1,1,1-tris-(L-methioninemethyl++ +)-ethane or H6L (11) has been synthesised in nine steps, and may mimic the release of iron from enterobactin to the agents which are directly involved in cell metabolism. The choice of methionine as a constituent of the siderophore incorporates divalent sulphur which leads to the increase of the reduction potential of the siderophore, and consequently facilitates the iron release [Fe(III)/Fe(II) redox potential E(1/2)=-0.749 V vs (SCE)].
authors: Laboratoire de Chimie de Coordination Bioorganique et Bioinorganique, ICMO URA-1384 du CNRS, Université de Paris-Sud, Orsay, France.
authors: N
authors: N
authors: Cheraïti
authors: M E
authors: ME
authors: Brik
authors: A
authors: A
authors: Gaudemer
authors: G
authors: G
authors: Kunesh
mesh_terms: D001419:Bacteria / Q000737:chemistry / Q000187:drug effects; D001426:Bacterial Proteins / Q000138:chemical synthesis / Q000378:metabolism; D004563:Electrochemistry; D004758:Enterobactin / Q000031:analogs & derivatives / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D007501:Iron / Q000378:metabolism; D008715:Methionine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D010084:Oxidation-Reduction / Q000187:drug effects
chemical_list: D001426:Bacterial Proteins; C119116:N-tris-(2,3-dihydroxybenzoyl)-1,1,1-tris-(methioninemethyl)-ethane; D004758:Enterobactin; D008715:Methionine; D007501:Iron